Surgical Revascularization Outcomes After Oral Anticoagulation or Antiplatelets
Status:
Unknown status
Trial end date:
2020-12-31
Target enrollment:
Participant gender:
Summary
The primary purpose of this study is to evaluate whether treatment with oral anticoagulation
or oral anticoagulation and aspirin is better than aspirin alone in cardiovascular outcomes
and saphenous graft patency in patients submitted to coronary artery bypass graft.
Phase:
Phase 3
Details
Lead Sponsor:
Centro Hospitalar e Universitário de Coimbra, E.P.E.